EFFICACY OF THE IMMUNOSUPPRESSIVE THERAPY AGAINST THE NEPHROTIC SYNDROME AMONG CHILDREN
Abstract
Key words: nephritic syndrome, immunosuppressive therapy, alkylating agents, cyclosporine, mycophenolate mofetil, children.
About the Authors
A.G. TimofeevaRussian Federation
T.V. Sergeeva
Russian Federation
T.V. Margieva
Russian Federation
T.S. Voznesenskaya
Russian Federation
O.V. Komarova
Russian Federation
A.N. Tsygin
Russian Federation
References
1. Clark A.G., Barratt T.M. Steroid Responsive Nephrotic Syndrome. In: Pediatric Nephrology. Ed. Barratt T.M., Avner E.D., Harmon W.E. 1999. P. 731–747.
2. International Study of Kidney Disease in Children. Early identification of frequent relapsers among children with minimal change nephrotic syndrome. J. Pediatr. 1982; 101: 514–518.
3. International Study of Kidney Disease in Children. The primary nephrotic syndrome in children. Identification of patients with minimal change nephrotic syndrome from initial response to prednisone. J. Pediatr. 1981; 98: 561–564.
4. Barratt T.M., Soothill J.F. Controlled trial of cyclophosphamide in steroid sensitive relapsing nephrotic syndrome of childhood. Lancet. 1970; 2: 479–482.
5. International Study of Kidney Disease in Children. Prospective controlled trial of cyclophosphamide in children with nephrotic syndrome. Lancet. 1974; 2: 423–427.
6. Barratt TM, Bercowsky A., Osofsky S.G. et al. Cyclophosphamide treatment in steroid-sensitive relapsing nephrotic syndrome of childhood. Lancet. 1975; 1: 55–58.
7. Garin E.H., Pryor N.D., Fennell R.S. et al. Pattern of response to prednisone in idiopathic minimal lesion nephrothic syndrome as a criterion selecting patients for cyclophosphamide therapy. J. Pediatr. 1978; 92: 304-308.
8. Geary D.F., Farine M., Thorner P. et al. Response to cyclophosphamide in steroid resistant focal segmental glomerulosclerosis. A reappraisal. Clin. Nephrol. 1984; 22: 109–113.
9. Niaudet P., Habib R. Cyclosporine in the treatment of idiopathic nephrosis. J. Am Soc. Nephrol. 1994; 5: 1049–1051.
10. Gellermann J., Querfeld U. Frequently relapsing nephrotic syndrome:treatment with mycophenolate mofetil. Pediatr. Nephrol. 2004; 19: 101–104.
11. Сергеева Т.В. Влияние комплексной терапии на течение и исход хронического гломерулонефрита у детей. Автореф. …дис. докт. наук. М. 1988. 46 с.
12. Moudgil A., Bagga A., Jordan S.C. Mycophenolate mofetil therapy infrequently relapsing steroid-dependent and steroid-resistant nephritic syndrome of childhood: current status and future directions. Pediatr. Nephrol. 2005; 20: 1376–1381.
13. Hsu A.C., Folami A.O., Bain J. et al. Gonadal functions in males treated with cyclophosphamide for nephrotic syndrome. Fertil. Steril. 1979; 31: 173–177.
14. Trompeter R.S., Evans P.R., Barratt T.M. Gonadal function in boys with steroid responsive nephrotic syndrome treated with cyclophosphamide for short periods. Lancet. 1981; 1: 1177–1179.
15. Buchanan J.D., Fairley K.F., Barris J.U. Return of spermatogenesis after stopping cyclophosphamide therapy. Lancet. 1975; 156–157.
16. Muller W., Brandis M. Acute leukemia after cytotoxic treatment for non malignant disease in childhood. Eur. J. Pediatr. 1981; 136: 105–108.
17. Niaudet P. Steroid-Resistant Idiopathic Nephrotic Syndrome. In: Barratt T.M, Avner E.D, Harmon W.E. Pediatric Nephrology. 1999. P.749–763
Review
For citations:
Timofeeva A., Sergeeva T., Margieva T., Voznesenskaya T., Komarova O., Tsygin A. EFFICACY OF THE IMMUNOSUPPRESSIVE THERAPY AGAINST THE NEPHROTIC SYNDROME AMONG CHILDREN. Current Pediatrics. 2007;6(5):113-116.